Cardiometabolic Effects of Empagliflozin in Patients Undergoing Elective Percu-taneous Coronary Intervention for Type 2 Diabetes Mellitus.

Overview of attention for article published in Kardiologiia, December 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,222 followers.

Cardiometabolic Effects of Empagliflozin in Patients Undergoing Elective Percu-taneous Coronary Intervention for Type 2 Diabetes Mellitus https://t.co/5NFAiWHsIv https://t.co/sTXWZ8EB8O

13 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.